https://www.avient.com/sites/default/files/2021-04/avnt-fourth-quarter-2020-news-release.pdf
EST on February 9, 2021.
https://www.avient.com/sites/default/files/2024-09/Terms and Conditions of Sale for Denmark.pdf
Parterne er enige om, at tiden ikke er
Seller may change the price and/or terms of delivery
and shipment at any time up until delivery, except
where a written alternative pricing mechanism ex-
ists that is signed by Seller.
https://www.avient.com/sites/default/files/2022-11/Avient Announces Third Quarter 2022 Results.pdf
EST.
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Press Release-1.pdf
EST.
https://www.avient.com/sites/default/files/2022-07/Avient Announces Second Quarter 2022 Results_1.pdf
EST.
https://www.avient.com/sites/default/files/2024-02/AVNT Q4 2023 Earnings Press Release.pdf
EST.
https://www.avient.com/sites/default/files/resources/Wells%2520Fargo%2520Conference%2520-%2520IR%2520Presentation%25205-6-2015%2520-%2520wNon%2520GAAP%2520and%2520Appendix.pdf
S&P 500
PolyOne Corporation Page 9
2006 Q1 2015 2015 Target
“Where we were” “Where we are” (Est. in 2012)
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 16.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 16.3% 12 – 16%
Designed Structures & Solutions 1.4% (2012) 2.7% 8 – 10%
Performance Products &
Solutions 5.5% 6.5% 9 – 12%
Distribution 2.6% 5.9% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 69% 65 – 75%
3) ROIC 5.0% 11.4% 15%
4) Adjusted EPS Growth N/A 5% Double Digit
Expansion
Proof of Performance & 2015 Goals
PolyOne Corporation Page 10
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 11
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 12
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
4
11
5
10
6
9
3 4 2
15
9
1
10
4
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 25 14 19 17 18 93
Addressable Market
($ millions) $800 $450 $450 $1,700
PolyOne Corporation Page 13
60%
98%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q1 2015
Pension Funding**
As of March 31, 2015
Debt Maturities & Pension Funding – 3/31/15
Net Debt / EBITDA* = 2.1x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2015
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2015
PolyOne Corporation Page 14
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased over
500k shares in Q1
2015
Repurchased 11.8
million shares since
early 2013
8.2 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 15
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 16
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2024-12/AVNT Investor Day 2024 Presentation.pdf
Free cash flow use
2020– 2024 est.
30%
37%
6%27%
Debt
paydown
Dividend
payments
Share
buybacks
M&A,
other
15% CAGR
Copyright © .
2024 62
Disciplined capital allocation
PRIORITIZATION AND PHILOSHOPY
Capex Expected annual spend between 3-5% of revenue to
support investment in organic growth
Dividends Increasing each year with underlying earnings growth
Debt pay down Target net debt to adjusted EBITDA less than 2.5x
Share repurchases Opportunistic buy backs
M&A De-emphasized in near term; complement organic growth strategy
with M&A over time, as needed
Copyright © .
2024 63
Avient is a compelling investment thesis
Ability to adapt & pivot to deliver results
highly motivated team with track record of
operational and commercial excellence
Global reach with local touch
customer-centric focus across continents and cultures
to serve locally and win globally
Innovation
differentiation by hybridizing technologies
to create platforms at scale
aligned to high growth market segments
and secular trends
MARGIN EXPANSION
and sustainable growth
ORGANIC GROWTH
complemented by M&A over time
as needed
Strong CASH GENERATION
and EXECUTION
Broad customer base and
COMPETITIVE ADVANTAGE
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Below is a reconciliation of non-GAAP financial measures to their most directly comparable financial measures calculated and
presented in accordance with GAAP.
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-port-a4.pdf
Este resumo não tem a
finalidade de ser completo.
https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2023-results
EST